Comparison of effect of sitagliptin and nateglinide on postprandial glucose level and secretion of insulin and glucagon after meal tolerance test in early type 2 diabetes.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2012
At a glance
- Drugs Sitagliptin (Primary) ; Nateglinide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 06 Apr 2011 New trial record